FUT2 Secretor Proxy — The Gut-Skin Axis at a Genetic Crossroads
Your FUT2 gene is the master switch for secretor status | Whether you express
ABO blood group antigens on mucosal surfaces and in saliva, tears, and intestinal
mucus — a trait that fundamentally shapes your gut microbiome and immune
landscape. rs492602 is a synonymous proxy variant that tags this biological
divide: the G allele travels with the secretor phenotype, while the A allele
travels with the non-secretor phenotype that arises from the nearby
W143X nonsense mutation | rs601338 (G428A) creates a premature stop codon at
amino acid 143 of FUT2, producing a truncated, non-functional enzyme; this is
the primary FUT2 non-secretor variant in Europeans and Africans (rs601338).
Although rs492602 itself is a silent coding change (alanine-68 codon remains
alanine), it serves as a reliable genomic proxy for the functional variant in
most populations.
The platform already tracks rs601338 in the vitamins-nutrients category, where
the focus is on B12 absorption. This entry covers the orthogonal angle: the
gut-skin axis | The bidirectional communication between the intestinal microbiome
and skin immune function, increasingly recognised as a driver of inflammatory
skin diseases including psoriasis and autoimmune susceptibility
that rs492602 tags independently. The two entries address distinct clinical
implications of the same underlying biology.
The Mechanism
FUT2 encodes alpha(1,2)-fucosyltransferase | An enzyme that adds the six-carbon
sugar fucose to glycan chains on the surface of intestinal epithelial cells and
into secreted mucus, creating the H antigen on which A and B blood group
specificities are built. In secretors, fucosylated glycans line the gut
wall and are shed into the intestinal lumen where they serve two purposes:
attachment scaffolds for certain pathogens (and therefore pathogen resistance
signals) and a dedicated carbon source for
Bifidobacterium | A genus of beneficial gut bacteria that have evolved
specialised fucosidase enzymes to harvest fucose from host glycans as their
primary food source in the gut species that have co-evolved with human
secretors.
Non-secretors produce no functional FUT2 enzyme and therefore no mucosal
fucosylated glycans. The immediate consequence is a profoundly altered
intestinal microbiome — reduced Bifidobacterium richness and diversity, and
an enrichment of bacteria that drive Th17-promoting inflammation. The gut
of a non-secretor is structurally predisposed to a different immunological
state from birth.
The Evidence
The secretor-microbiome connection was firmly established by
Wacklin et al. 2011 | Wacklin P et al. Secretor genotype (FUT2 gene) is
strongly associated with the composition of Bifidobacteria in the human
intestine. PLoS One,
2011: in 71 healthy volunteers,
non-secretors showed significantly reduced bifidobacterial richness (p<0.0001)
and several key species (B. bifidum, B. adolescentis, B. catenulatum) were
absent or rare in non-secretors but common in secretors.
The link between FUT2 non-secretor status and Crohn's disease was established
by a genome-wide association study in
4,100 Caucasian participants | McGovern DPB et al. Fucosyltransferase 2 (FUT2)
non-secretor status is associated with Crohn's disease. Hum Mol Genet,
2010 reaching genome-wide
significance (P=4.90×10⁻⁸). Mechanistically,
Tong et al. 2014 | Tong M et al. Reprograming of gut microbiome energy
metabolism by the FUT2 Crohn's disease risk polymorphism. ISME J,
2014 demonstrated that the
non-secretor microbiome shows depleted amino-acid biosynthesis and enriched
carbohydrate catabolism pathways, accompanied by sub-clinical mucosal
inflammation in non-secretors even before disease onset.
The psoriasis association was identified in a Han Chinese case-control study
Liu et al. 2021 | Liu Y et al. Association of Polymorphisms of
Metabolism-Related Genes with Psoriasis Vulgaris in Han Chinese. Biomed Res
Int, 2021 of 1,030 psoriasis
patients and 965 controls (OR=1.86, P=0.005). The association was stronger
in individuals without the HLA-C*06:02 allele (OR=2.04), suggesting rs492602
contributes to psoriasis risk through a pathway partially independent of the
canonical HLA-driven pathway. This is consistent with the gut-skin axis
hypothesis: altered microbial composition drives systemic immune dysregulation
that manifests in skin inflammation. Importantly, rs492602 sits in a genomic
region with documented shared susceptibility for both psoriasis and Crohn's
disease, supporting a common gut-immune mechanism.
A large Dutch microbiome GWAS
Lopera-Maya et al. 2022 | Lopera-Maya EA et al. Effect of host genetics on
the gut microbiome in 7,738 participants of the Dutch Microbiome Project.
Nat Genet, 2022 confirmed
FUT2/secretor status as one of only two robust genome-wide significant
genetic determinants of gut microbial composition, with a p-value below
1.89×10⁻¹⁰ — placing this among the most reproducible host-microbiome
genetic associations in the human genome.
LD with rs601338: rs492602 is in strong LD with the functional W143X
nonsense variant (rs601338) in European and African populations. The two
variants are highly correlated, which is why rs492602 served as the GWAS
tag SNP for B12 levels in the original Hazra et al. 2008 discovery. In East
Asian populations, both variants are rare; the primary non-secretor allele
there is rs1047781 (A385T). This entry focuses on the autoimmune and
gut-skin axis biology; see the rs601338 entry for B12 absorption details.
Practical Actions
For non-secretors (AA), the gut-immune implications are the most actionable
aspect of this variant. Supporting microbial diversity through prebiotic-rich
foods and targeted Bifidobacterium probiotics can partially compensate for
the structural deficit in mucosal glycan availability. Monitoring for early
signs of gut inflammation is warranted given the elevated Crohn's risk.
For psoriasis specifically, the gut-skin axis implication means that gut
microbiome health strategies may have downstream benefit for skin inflammation —
though direct clinical evidence for probiotics modifying psoriasis severity
in non-secretors specifically is not yet available.
Interactions
This variant is in strong LD with rs601338 (FUT2 W143X), which is separately
catalogued for B12 metabolism. If you carry the A allele at rs492602, you
very likely also carry the A (non-secretor) allele at rs601338. The two
entries address different clinical angles of the same biology.
rs602662 (FUT2 S258G) is also in LD with this locus and shows similar
Crohn's disease associations. In East Asian populations, rs1047781 (A385T)
is the primary secretor-status determinant and should be checked in that
ancestry context.
Alla genotyper
Full secretor — optimal gut microbiome diversity and reduced autoimmune risk
You carry two G alleles at rs492602, the variant associated with full secretor status. Your FUT2 gene produces functional enzyme that coats your gut lining with fucosylated glycans, supporting a diverse Bifidobacterium-rich microbiome. About 21% of the global population shares this genotype (roughly 22% of Europeans). Your gut architecture is well-suited to nourishing beneficial bacteria through host-derived glycans. Your risk for FUT2-mediated Crohn's disease and psoriasis susceptibility is reduced compared to non-secretors.
Non-secretor — reduced gut microbiome diversity, elevated Crohn's disease and psoriasis risk
You carry two A alleles at rs492602, tagging the non-secretor phenotype. Your gut lining does not produce the fucosylated glycans that nourish Bifidobacterium species and regulate intestinal immune responses. About 29% of the global population and roughly 28% of Europeans share this genotype (extremely rare in East Asians, ~0.1%). Your gut microbiome shows lower bifidobacterial diversity, a pattern linked to increased risk for Crohn's disease and, via the gut-skin axis, psoriasis susceptibility. The A allele at rs492602 is in strong LD with the functional W143X nonsense variant at rs601338.
Secretor with one non-secretor allele — full secretor function, carrier status
You carry one G (secretor) and one A (non-secretor proxy) allele. Because secretor status follows a recessive pattern, one functional FUT2 copy is sufficient to maintain full mucosal fucosylation. You are functionally a secretor with normal gut glycan production. This is the most common genotype globally — about 50% of Europeans carry it. Your risk profile for FUT2-mediated Crohn's disease and psoriasis is similar to GG carriers. You can pass the A allele to your children.